131 related articles for article (PubMed ID: 20944153)
1. Novel chemoradiosensitizers for cancer therapy.
Page P; Yang LX
Anticancer Res; 2010 Sep; 30(9):3675-82. PubMed ID: 20944153
[TBL] [Abstract][Full Text] [Related]
2. New and emerging radiosensitizers and radioprotectors.
Spalding AC; Lawrence TS
Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
Chen AY; Chou R; Shih SJ; Lau D; Gandara D
Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
[TBL] [Abstract][Full Text] [Related]
4. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
5. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin.
Coughlin CT; Richmond RC
Semin Oncol; 1989 Aug; 16(4 Suppl 6):31-43. PubMed ID: 2669136
[TBL] [Abstract][Full Text] [Related]
6. Modification of radiotherapy by radiosensitizers and cancer chemotherapeutic agents. II. Cancer chemotherapeutic agents.
Looney WB; Hopkins HA
Semin Oncol; 1989 Jun; 16(3):176-9. PubMed ID: 2658081
[No Abstract] [Full Text] [Related]
7. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; FĂ©lix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
8. Past, current and future protocols for combined modality therapy in childhood medulloblastoma.
Kaaijk P; Schouten-van Meeteren AY; Slotman BJ; Kaspers GJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):79-90. PubMed ID: 12597352
[TBL] [Abstract][Full Text] [Related]
9. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
Bentzen SM; Harari PM; Bernier J
Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
[TBL] [Abstract][Full Text] [Related]
10. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
Francis D; Richards GM; Forouzannia A; Mehta MP; Khuntia D
Expert Opin Pharmacother; 2009 Sep; 10(13):2171-80. PubMed ID: 19640206
[TBL] [Abstract][Full Text] [Related]
11. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Coleman CN
Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
[No Abstract] [Full Text] [Related]
12. [Perspectives in biological modulation of radiotherapy].
Deutsch E; Huguet F
Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Miller AR; Pisters PW; Lee JE; Janjan NA; Abbruzzese JL; Evans DB
Hepatogastroenterology; 1998; 45(21):624-33. PubMed ID: 9684107
[TBL] [Abstract][Full Text] [Related]
14. Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors.
Khuntia D; Mehta M
Expert Rev Anticancer Ther; 2004 Dec; 4(6):981-9. PubMed ID: 15606327
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy.
Piekarz RL; Sackett DL; Bates SE
Cancer J; 2007; 13(1):30-9. PubMed ID: 17464244
[TBL] [Abstract][Full Text] [Related]
16. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly(ADP-ribose) polymerase in cancer.
Plummer ER
Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
[TBL] [Abstract][Full Text] [Related]
20. Strategies for enhancing viral-based gene therapy using ionizing radiation.
Chmura SJ; Advani SJ; Kufe DW; Weichselbaum RR
Radiat Oncol Investig; 1999; 7(5):261-9. PubMed ID: 10580895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]